What is Regard?
Regard is a healthcare technology company focused on revolutionizing clinical documentation and decision support through artificial intelligence. Its platform is engineered to help healthcare organizations unlock the full potential of patient data by analyzing clinical information in real time. This enables the identification of critical insights, provides robust support for care decisions, and streamlines documentation workflows. By integrating AI-driven actionable intelligence into clinician workflows, Regard aims to enhance patient outcomes, alleviate administrative burdens, boost operational efficiency, and optimize financial performance for health systems. The company's core mission is to empower healthcare providers to leverage data more effectively, ultimately leading to higher quality patient care.
How much funding has Regard raised?
Regard has raised a total of $106.3M across 2 funding rounds:
Series A
$15.3M
Series B
$91M
Series A (2022): $15.3M with participation from TenOneTen Ventures, Susa Ventures, Calibrate Ventures, and Foundry Group
Series B (2024): $91M led by Oak HC/FT, Techstars, and Calibrate Ventures
Key Investors in Regard
Oak HC/FT
Oak HC/FT is a venture growth-equity fund specializing in Healthcare Information & Services and Financial Services Technology. They provide strategic counsel and access to an extensive network to drive transformation in these industries.
Calibrate Ventures
Calibrate Ventures is a venture capital firm that invests in early-revenue companies leveraging advanced software, automation, and AI to reshape industries. They offer financing and operational guidance to accelerate growth.
Susa Ventures
Susa Ventures is an early-stage venture capital firm that invests in seed-stage startups, providing capital and community without taking board seats to foster founder control.
What's next for Regard?
The recent major strategic investment of $91M positions Regard for accelerated growth and market expansion. As a company that has now achieved a significant enterprise-level funding milestone, Regard is likely to focus on scaling its operations, further developing its AI capabilities, and broadening its market reach within the healthcare industry. This capital infusion is expected to fuel innovation in its clinical documentation and decision support solutions, enabling the company to solidify its competitive advantage and address the evolving needs of healthcare providers seeking to optimize patient data utilization and operational efficiency.
See full Regard company page
